Siwanon Jirawatnotai
Overview
Explore the profile of Siwanon Jirawatnotai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suwanvecho S, Kiatikajornthada N, Phikulsod P, Suwanrusme H, Jirawatnotai S
Case Rep Oncol
. 2025 Feb;
18(1):130-136.
PMID: 39980517
Introduction: Chemotherapy combined with anti-human epidermal growth factor receptor 2 (HER2)-targeted therapy is currently a standard treatment for advanced HER2/HR-positive breast cancer (BC), although evidences showed that HR expression compromised...
2.
Yaikwawong M, Ek-Eudomsuk P, Sittithumcharee G, Anupunpisit V, Peerapatdit T, Deerochanawong C, et al.
Sci Rep
. 2025 Feb;
15(1):4351.
PMID: 39910148
No abstract available.
3.
Lerksuthirat T, Prasopporn S, Wikiniyadhanee R, Chitphuk S, Stitchantrakul W, Owneium P, et al.
Oncol Lett
. 2025 Jan;
29(3):128.
PMID: 39822940
Cholangiocarcinoma (CCA) is a biliary tract carcinoma that is challenging to treat due to its heterogeneity and limited treatment options. Genetic alterations in DNA damage response (DDR) pathways and homologous...
4.
Venkatraman S, Balasubramanian B, Kongpracha P, Yangngam S, Chuangchot N, Khanaruksombat S, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766097
Background: Cancer immune evasion is a multifaceted process that synchronizes pro-tumoral immune infiltration, immunosuppressive inflammation, and inhibitory immune checkpoint expression (IC). Current immunotherapies combat this issue by reinstating immunosurveillance of...
5.
Yaikwaong M, Yaikwawong M, Ek-Eudomsuk P, Sittithumcharee G, Anupunpisit V, Peerapatdit T, et al.
Sci Rep
. 2024 Nov;
14(1):27616.
PMID: 39528503
This study investigated the associations between CAV1 variants and metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM), and cardiometabolic risk factors, as well as the influence of CAV1 variants on...
6.
Areewong S, Suppramote O, Prasopporn S, Jirawatnotai S
Cancer Cell Int
. 2024 Nov;
24(1):362.
PMID: 39501277
Cholangiocarcinoma (CCA) presents a formidable therapeutic challenge due to its extensive heterogeneity and plasticity, which inevitably lead to acquired resistance to current treatments. However, recent evidence suggests that acquired drug...
7.
Wongprayoon P, Pengnam S, Srisuphan R, Opanasopit P, Jirawatnotai S, Charoensuksai P
PLoS One
. 2024 Oct;
19(10):e0312173.
PMID: 39413067
The upregulation of O-GlcNAc signaling has long been implicated in the development and progression of numerous human malignancies, including colorectal cancer. In this study, we characterized eight colorectal cancer cell...
8.
Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S
Nutr J
. 2024 Oct;
23(1):119.
PMID: 39354480
Background: Type 2 diabetes mellitus (T2DM) is a chronic condition characterized by insulin resistance and impaired insulin production, leading to elevated blood glucose levels. Curcumin, a polyphenolic compound from Curcuma...
9.
Kongtanawanich K, Prasopporn S, Jamnongsong S, Thongsin N, Payungwong T, Okada S, et al.
Sci Rep
. 2024 Sep;
14(1):22619.
PMID: 39349745
Cancer stem cells (CSC) play an important role in carcinogenesis and are acknowledged to be responsible for chemoresistance in cholangiocarcinoma (CCA). Studying CCA CSC has been challenging, due to lack...
10.
Yaikwawong M, Jansarikit L, Jirawatnotai S, Chuengsamarn S
Nutrients
. 2024 Aug;
16(15).
PMID: 39125322
Curcumin, derived from turmeric root, exhibits notable anti-inflammatory effects. These anti-inflammatory properties might also provide advantages in reducing cardiovascular complications, such as atherosclerosis. This study aimed to evaluate the efficacy...